New anti-obesity medicines can help stem the rising tide of obesity. But outdated rules make access to these new medicines ...
The FDA has approved lebrikizumab (Ebglyss; Eli Lilly) as a new first-line biologic treatment for patients aged 12 and older ...
Weight-loss jabs Ozempic and Wegovy have been touted as miracle jabs revolutionizing how obesity is treated. Now the maker of these drugs is touting a new weight-loss pill that is said to help obese ...